OpenBiome Announces New Collaboration with the University of Minnesota to Treat Patients with Recurrent C. difficile Infections (Open Biome)

CAMBRIDGE, MA—OpenBiome is announcing a collaboration with the University of Minnesota’s Microbiota Therapeutics Program to ensure that patients with recurrent C. difficile infections have access to fecal microbiota transplantation (FMT) until an FDA-approved alternative is available.